Humana Inc. $HUM Shares Newly Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Humana Inc. (NYSE:HUM) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 36,832 shares of the insurance provider’s stock, valued at approximately $14,054,000.

Other large investors have also recently made changes to their positions in the company. Manning & Napier Advisors LLC purchased a new stake in shares of Humana during the second quarter valued at approximately $1,412,000. Vista Investment Partners LLC purchased a new position in Humana in the 3rd quarter worth approximately $3,254,000. The Manufacturers Life Insurance Company raised its holdings in Humana by 10.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 70,185 shares of the insurance provider’s stock worth $27,879,000 after acquiring an additional 6,690 shares during the last quarter. Pzena Investment Management LLC purchased a new position in Humana in the 2nd quarter worth approximately $1,749,014,000. Finally, Ameritas Advisory Services LLC bought a new position in Humana in the 2nd quarter valued at approximately $1,709,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on HUM. Lake Street Capital initiated coverage on Humana in a research note on Thursday, July 30th. They set a “buy” rating on the stock. HSBC lowered Humana to a “hold” rating in a report on Thursday, July 30th. Guggenheim boosted their price target on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Wall Street Zen downgraded Humana from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Wolfe Research reaffirmed an “outperform” rating and set a $450.00 price objective on shares of Humana in a research report on Monday, August 24th. Twenty-one analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Humana has an average rating of “Moderate Buy” and a consensus price target of $453.30.

Humana Stock Up 1.8%

HUM opened at $417.70 on Wednesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a 50 day moving average price of $402.16 and a 200-day moving average price of $310.09. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $456.50. The stock has a market capitalization of $50.16 billion, a price-to-earnings ratio of 39.52, a PEG ratio of 2.53 and a beta of 0.65.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be given a $0.8850 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s payout ratio is 33.49%.

About Humana

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.